These constraints on the BTNX NTS are remarkably appropriate, as we uncovered e.g. etodesnitazene to have an analogous in vitro potency and efficacy as fentanyl [7, 13] and as it may potentially give PWUD a false feeling of security. Moreover, the detectability of nitazene analogues in drug samples may very well be impacted by solubility troubles,